Publication: 2998

Publication: 2998

PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials

URL

Google Scholar

Citation:: Annal Oncol vol 29 (suppl_8) Abstr LBA34

Meeting Instance:: ESMO 2018
Year:: 2018
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3111

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Exelixis
Grants:: U10CA180821, U24CA196171

Corr. Author:
Authors:: T.K. Choueiri A. Flaifel W. Xie D. Braun M. Ficial R. Jennings A. Nassar B. Escudier D.J. George R.J. Motzer M.J. Morris T. Powles E. Wang Y. Huang G. Freeman S. Signoretti

Networks:: LAPS-CT018, LAPS-MA036, LAPS-NC010, LAPS-NY016, LAPS-NY158, LAPS-UT003, NC002

Study: Alliance-A031203
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: